Cabozantinib and Nivolumab As First-Line Treatment in Advanced Renal Cell Carcinoma.
Expert Review of Anticancer Therapy（2021）
Key words
Cabozantinib,immune checkpoint inhibitors,metastatic renal cell carcinoma,multiple tyrosine kinase inhibitors,nivolumab
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined